Cargando…
Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC), which represents approximately 90% of all pancreatic cancers, is an extremely aggressive and lethal disease. It is considered a silent killer due to a largely asymptomatic course and late clinical presentation. Earlier detection of the disease...
Autores principales: | Brezgyte, Greta, Shah, Vinay, Jach, Daria, Crnogorac-Jurcevic, Tatjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198035/ https://www.ncbi.nlm.nih.gov/pubmed/34072842 http://dx.doi.org/10.3390/cancers13112722 |
Ejemplares similares
-
Non-Invasive Biomarkers for Early Lung Cancer Detection
por: Saman, Harman, et al.
Publicado: (2022) -
Response to the comment on “Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients”
por: Blyuss, Oleg, et al.
Publicado: (2020) -
S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
por: Srivastava, K., et al.
Publicado: (2023) -
A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case–control study
por: Debernardi, Silvana, et al.
Publicado: (2020) -
Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis
por: Debernardi, Silvana, et al.
Publicado: (2022)